(Total Views: 576)
Posted On: 08/22/2021 4:32:08 PM
Post# of 145887
I decided to check endpoints of sacituzumab govitecan's trials. No mOS as an endpoint. I did see that they excluded patients with brain metastasis. I do know at least one of our patients had brain metastasis. If there were several and still managed to beat sacituzumab govitecan that would be truly remarkable.
(4)
(0)